Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04241224 · ClinicalTrials.gov registry record · NA
A Prospective, Multicenter Atherectomy Study Showing Luminal Gain in Subjects With Peripheral Vascular Blockages
A NA study of Peripheral Arterial Disease, sponsored by Ra Medical Systems.
- Completed
- Registry status
- NA
- Development phase
- 108
- Enrollment target
- 10
- Study locations
NCT04241224 is a NA study of Peripheral Arterial Disease that has completed, run by Ra Medical Systems. The registered enrollment target is 108 participants, below the 4,205-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (97% lower). The trial reports 10 study locations across 5 states.
The verdict
NCT04241224, a NA study of Peripheral Arterial Disease, has completed, sponsored by Ra Medical Systems.
- COMPLETED
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
- 10
- Study locations
Study Summary
To evaluate the safety and effectiveness of the DABRA Laser System in the atherectomy of peripheral vascular stenoses.
Conditions Studied
Interventions
- DEVICE Atherectomy
Study Locations (10)
Texas
- South Texas Vascular Institute - Edinburg
- Texas Tech University Health Sciences Center - Center for Cardiovascular Health - Lubbock
- Laser Surgical Solutions - McAllen
California
- California Heart & Vascular Clinic - El Centro
- Merced Vein & Vascular Center - Merced
Florida
- The Cardiac & Vascular Institute - Gainesville
- Vascardio Heart and Vascular Institute - Hialeah
Illinois
- MIMIT Health - Chicago
- MIMIT Health - Glen Ellyn
Michigan
- Eastlake Cardiovascular - Roseville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2020-02-26 |
| Est. Completion | 2022-11-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04241224
The ClinicalTrials.gov registry entry for NCT04241224 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,205-participant average among 79 other Peripheral Arterial Disease trials with a reported enrollment target (97% lower). The listed sponsor is Ra Medical Systems, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Peripheral Arterial Disease appearing as the primary indexed condition, and to 1 intervention - of which Atherectomy is the first listed.
NCT04241224 reports 10 study locations spanning 5 distinct geographic areas - top geographies include Texas, California, Florida.
Frequently Asked Questions
What is clinical trial NCT04241224 about?
NCT04241224 is a clinical study titled "A Prospective, Multicenter Atherectomy Study Showing Luminal Gain in Subjects With Peripheral Vascular Blockages". To evaluate the safety and effectiveness of the DABRA Laser System in the atherectomy of peripheral vascular stenoses.
What is the current status of trial NCT04241224?
This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2020-02-26. Estimated completion is 2022-11-17.
What conditions does trial NCT04241224 study?
This clinical trial studies the following conditions: Peripheral Arterial Disease.
What interventions are being tested in trial NCT04241224?
The interventions under investigation include: Atherectomy (DEVICE).
Who is sponsoring clinical trial NCT04241224?
This trial is sponsored by Ra Medical Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04241224 being conducted?
This trial has 10 study locations across California, Florida, Illinois, Michigan, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Arterial Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SELUTION4BTK Trial
RECRUITING · NA
-
MitoQ Treatment of Claudication: Myofiber and Micro-vessel Pathology
RECRUITING · NA
-
Ultrasound Perfusion Estimation for Assessment of Peripheral Arterial Disease
RECRUITING · NA
-
Prehabilitation and Rehabilitation in PAD
RECRUITING · NA
-
Replexa+ Shortwave Diathermy Device for Patients Diagnosed With Peripheral Artery Disease and Peripheral Neuropathy
RECRUITING · NA
-
Assessment of the Utility of the Pantheris Small Vessel (SV) System
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.